<unk>  is a Tumor Necrosis Factor Blocker that is FDA approved for the {{{indicationType}}} of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Ulcerative Colitis, Plaque Psoriasis. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include Injection site pain, Injection site reaction, Rash, Antibody development, to<unk>  ,Antinuclear antibody positive , Headache, Sinusitis, Upper respiratory infection.
Adalimumab
Etanercept
Belatacept
Abatacept
Tofacitinib
Aldesleukin
Nebacumab
Sarilumab